- 3301. Ovarian Vein
- (UMLS (NCI) C0226720) =Body Part, Organ, or Organ Component
| - 3351. ovulation time
- [ ] (UMLS (CSP) C0597148) =Temporal Concept ;
=ovulation detection/prediction;
|
- 3302. OVARIAN WEDGE RESECTION
- [ ] (UMLS (ICD9CM) C0177156) =Therapeutic or Preventive Procedure
| - 3352. Ovule
- [A container either glass or plastic and a narrow neck, for storing liquid. ( HL7V3.0 )] (UMLS (HL7) C1553473) =Manufactured Object =IndividualPackageEntityType;
|
- 3303. Ovarian Yolk Sac Tumor Stage I
- [Stage I includes: (T1, N0, M0). Also, IA: (T1a, N0, M0); IB: (T1b, N0, M0); IC (T1c, N0, M0). T1: Tumor limited to ovaries (one or both). T1a: Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings. T1b: Tumor limited to one or both ovaries; capsules intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings. T1c: Tumor limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th Ed.) - 2003 ( NCI )] (UMLS (NCI) C1336474) Stage I Ovarian Yolk Sac Tumor;
Yolk Sac Tumor of Ovary Stage I;
Yolk Sac Tumor of the Ovary Stage I =Neoplastic Process | - 3353. ovum transfer surgery
- [ ] (UMLS (CSP) C0920759) =Therapeutic or Preventive Procedure
|
- 3304. Ovarian Yolk Sac Tumor Stage II
- [Stage II includes: (T2, N0, M0). Also, IIA: (T2a, N0, M0); IIB: (T2b, N0, M0); IIC: (T2c, N0, M0). T2: Tumor involves one or both ovaries with pelvic extension and/or implants. T2a: Extension and/or implants on uterus and/or tube(s). No malignant cells in ascites or peritoneal washings. T2b: Extension to and/or implants on other pelvic tissues. No malignant cells in ascites or peritoneal washings. T2c: Pelvic extension and/or implants (T2a or T2b) with malignant cells in ascites or peritoneal washings. N0: No regional metastasis. (AJCC 6th Ed.) - 2003 ( NCI )] (UMLS (NCI) C1336310) Stage II Ovarian Yolk Sac Tumor;
Yolk Sac Tumor of Ovary Stage II;
Yolk Sac Tumor of the Ovary Stage II =Neoplastic Process | - 3354. Ovuplant
- (UMLS (NCI) C0378713) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
|
- 3305. Ovarian Yolk Sac Tumor Stage III
- [Stage III includes: (T3, N0, M0). Also, IIIA: (T3a, N0, M0); IIIB (T3b, N0, M0); IIIC (T3c N0, M0) and (Any T, N1, M0). T3: Tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis. T3a: Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor). T3b: Macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension. T3c: Peritoneal metastasis beyond pelvis more than 2cm in greatest dimension and/or regional lymph node metastasis. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th Ed.) - 2003 ( NCI )] (UMLS (NCI) C1336263) Stage III Ovarian Yolk Sac Tumor;
Yolk Sac Tumor of Ovary Stage III;
Yolk Sac Tumor of the Ovary Stage III =Neoplastic Process | - 3355. owl
- [members of the Strigiformes order of birds, with strongly hooked beaks, sharp talons, large heads, forward facing eyes, and facial disks; while considered nocturnal raptors, some owls do hunt by day. ( CSP )] (UMLS (CSP) C0326067) =Bird =Aves;
|
- 3306. Ovarian Yolk Sac Tumor Stage IV
- [Stage IV includes: (Any T, Any N, M1). M1: Distant metastasis (excludes peritoneal metastasis. (AJCC 6th Ed.) - 2003 ( NCI )] (UMLS (NCI) C1336433) Stage IV Ovarian Yolk Sac Tumor;
Yolk Sac Tumor of Ovary Stage IV;
Yolk Sac Tumor of the Ovary Stage IV =Neoplastic Process | - 3356. owl monkey
- [ ] (UMLS (CSP) C0324846) =Mammal
|
- 3307. ovariectomy - unilateral
- [Surgery to remove one ovary. ( NCI )] (UMLS (NCI) C0041687) =Therapeutic or Preventive Procedure
| - 3357. owl monkey herpesvirus
- [ ] (UMLS (CSP) C0598591) =Virus
|
- 3308. ovary transplantation
- [ ] (UMLS (CSP) C1261016) TRANSPLANTATION OF OVARY =Therapeutic or Preventive Procedure
| - 3358. owned entity
- [An Entity (player) for which someone (scoper) is granted by law the right to call the material (player) his own. This entitles the scoper to make decisions about the disposition of that material. ( HL7V3.0 )] (UMLS (HL7) C1550597) =Idea or Concept =RoleClassPassive;
|
- 3309. Over
- (UMLS (NCI) C0205136) =Spatial Concept
| - 3359. Owner
- (UMLS (HL7) C1546511) =Idea or Concept =Association;
|
- 3310. Overactive child/hyperkinetic
- (UMLS (ICPC) C0497320) (Overactive child/hyperkinetic; HAUR HIPERAKTIBOA/HIPERKINETIBOA; Hyperaktivt barn; Overactief kind/hyperkin syndroom; YLIAKTIIVINEN/HYPERKINEETTINEN LAPSI; Enfant hyperactif/hyperkinetique; ueberaktives/hyperkinetisches Kind; hiperaktiviut etzel yeled; tulz. aktiv/hyperkinetikus gyerek; Bambino iperattivo/ipercinetico; HYPERAKTIVT BARN; Crianca hiperactiva/hipercinetica; Nino hiperactivo/hipercinetico; OVERDRIVET LIVLIGT/HYPERAKTIVT BARN) =Sign or Symptom =Symptoms and Complaints Component; PSYCHOLOGICAL
| - 3360. Ownership
- [The legal relation in which a person or group entity has a financial interest in, dominion of, or control over an object or property. ( NCI )] (UMLS (NCI) C0029981) =Quantitative Concept
|
- 3311. Overall Claim Disposition Code
- (UMLS (HL7) C1547835) =Intellectual Product =HL7 Vocabulary Version 2.5;
=No edits present on claim;
Only edits present are for line item denial or rejection;
Multiple-day claim with one or more days denied or rejected;
Claim denied, rejected, suspended or returned to provider with only post payment edits;
Claim denied, rejected, suspended or returned to provider with only pre payment edits;
| - 3361. OXACILLIN
- [A semisynthetic penicillinase-resistant and acid-stable penicillin with an antimicrobial activity. Oxacillin binds to penicillin-binding proteins in the bacterial cell wall, thereby blocking the synthesis of peptidoglycan, a critical component of the bacterial cell wall. This leads to inhibition of cell growth and causes cell lysis. ( NCI )] (UMLS (NCI) C0029983) =Organic Chemical; Antibiotic ;
=Penicillanic Acid;
[AM053] PENICILLINASE-RESISTANT PENICILLINS =CLOXACILLIN;
OXACILLIN SODIUM |
- 3312. OVERANXIOUS DISORDER
- [ ] (UMLS (ICD9CM) C0270307) =Mental or Behavioral Dysfunction
| - 3362. oxalate
- [strong dicarboxylic acid or its salts or esters occurring in many plants; produced in the body by metabolism of glyoxylic acid or ascorbic acid; not metabolized but excreted in the urine. ( CSP )] (UMLS (CSP) C0029988) =Organic Chemical =dicarboxylate;
|
- 3313. Overdenture
- [A complete denture with additional support from remaining teeth that have been reshaped or altered prosthetically to permit the denture to fit over them. ( NCI )] (UMLS (NCI) C0011459) =Medical Device
| - 3363. Oxaliplatin/Paclitaxel
- (UMLS (NCI) C0879353) =Therapeutic or Preventive Procedure ;
|
- 3314. Overdose
- (UMLS (HL7) C1546941) =Idea or Concept =Event Qualification;
| - 3364. Oxaliplatin/Topotecan
- (UMLS (NCI) C0935701) =Therapeutic or Preventive Procedure
|
- 3315. Overdose of radiation in therapy
- [ ] (UMLS (ICD9CM) C0481248) =Injury or Poisoning
| - 3365. oxaloacetate
- [class of ketodicarboxylic acids, or their salts or esters, derived from oxalic acid; oxaloacetate is an intermediate in the citric acid cycle and is converted to aspartate by a transamination reaction. ( CSP )] (UMLS (CSP) C0029989) =Organic Chemical =dicarboxylate;
|
- 3316. Overdue / Post-term
- (UMLS (HL7) C1547237) =Intellectual Product =Gestation Category Code;
| - 3366. oxalosis
- [ ] (UMLS (CSP) C1298681) =Disease or Syndrome
|
- 3317. Overflow
- (UMLS (HL7) C1548574) =Intellectual Product =Location characteristic ID;
| - 3367. OXAMNIQUINE
- [An anthelmintic with schistosomicidal activity against Schistosoma mansoni, but not against other Schistosoma spp. Oxamniquine causes worms to shift from the mesenteric veins to the liver where the male worms are retained; the female worms return to the mesentery, but can no longer release eggs. (From Martidale, The Extra Pharmacopoeia, 31st ed, p121) ( MSH )] (UMLS (NCI) C0029994) =Organic Chemical; Pharmacologic Substance ;
=Anthelminthics;
Hydroxyquinolines;
Nitroquinolines;
|
- 3318. OVERFLOW INCONTINENCE
- [ ] (UMLS (ICD9CM) C0312413) =Finding ;
| - 3368. Oxandrin
- (UMLS (NCI) C0728775) =Organic Chemical; Pharmacologic Substance; Hormone
|
- 3319. OVERHANG DENTAL RESTORE
- [ ] (UMLS (ICD9CM) C1719510) Unrepairable overhanging of dental restorative =Disease or Syndrome
| - 3369. OXANDROLONE
- [synthetic hormone with androgenic and anabolic properties. ( CSP )] (UMLS (NCI) C0029995) =Steroid; Pharmacologic Substance; Hormone =androgen analog;
Androstanols;
[HS100] ANDROGENS/ANABOLICS;
=OXANDROLONE 2.5 MG;
OXANDROLONE 10 MG |
- 3320. overlay ROI
- [A Region of Interest (ROI) specified for an image using an overlay shape. Typically used to make reference to specific regions in images, e.g., to specify the location of a radiologic finding in an image or to specify the site of a physical finding by "circling" a region in a schematic picture of a human body. The units of the coordinate values are in pixels. The origin is in the upper left hand corner, with positive X values going to the right and positive Y values going down. The relationship between a ROI and its referenced Act is specified through an ActRelationship of type "subject" (SUBJ), which must always be present. ( HL7V3.0 )] (UMLS (HL7) C1553506) =Idea or Concept =ActClassROI;
| - 3370. oxazine
- [Six-membered heterocycles containing an oxygen and a nitrogen. ( MSH )] (UMLS (CSP) C0030001) =Organic Chemical ;
=Heterocyclic Compounds, 1-Ring;
nitrogenous heterocyclic compound;
oxygenous heterocyclic compound;
=flavin;
morpholine;
Efavirenz;
2-oxo-N,3-bis-(2-chloroethyl) tetrahydro-2H-1,3,2-oxazaphosphorin- 2-amine;
morpholine;
L 743726 |
- 3321. Overnight
- (UMLS (NCI) C0439583) =Temporal Concept
| - 3371. oxaziridine
- [ ] (UMLS (CSP) C0597947) =Organic Chemical; Pharmacologic Substance
|
- 3322. overpopulation
- [ ] (UMLS (CSP) C0029949) =Quantitative Concept
| - 3372. oxazole
- [five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position. ( CSP )] (UMLS (CSP) C0030004) =Organic Chemical ;
=azole;
Heterocyclic Compounds, 1-Ring =isoxazole;
oxazolidone;
isoxazole;
2-Imino-4-keto-5-phenyltetrahydrooxazole;
2,4-Oxazolidinedione, 3,5,5-trimethyl-;
PARAMETHADIONE;
Oxazolidinones;
|
- 3323. overpopulation
- [ ] (UMLS (CSP) C0677044) =Quantitative Concept
| - 3373. oxazolidinedione
- [ ] (UMLS (CSP) C0304361) =Organic Chemical; Pharmacologic Substance
|
- 3324. Override
- (UMLS (HL7) C1547671) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Override allowed;
Override required;
Override not allowed;
| - 3374. oxazolidone
- [derivatives of oxazole; a class of synthetic antibiotic agents. ( CSP )] (UMLS (CSP) C0597149) =Organic Chemical ;
=oxazole;
|
- 3325. Override allowed
- (UMLS (HL7) C1548367) =Idea or Concept =Override;
| - 3375. oxazolinone
- [ ] (UMLS (CSP) C0597150) =Organic Chemical ;
|
- 3326. Override code
- (UMLS (HL7) C1547895) =Intellectual Product =HL7 Vocabulary Version 2.5;
| - 3376. oxepane
- [ ] (UMLS (CSP) C0597151) =Organic Chemical ;
|
- 3327. Override not allowed
- (UMLS (HL7) C1548369) =Idea or Concept =Override;
| - 3377. oxepin
- [Compounds based on a 7-membered heterocyclic ring including an oxygen. They can be considered a medium ring ether. A natural source is the MONTANOA plant genus. Some dibenzo-dioxepins, called depsidones, are found in GARCINIA plants. ( MSH )] (UMLS (CSP) C0030007) =Organic Chemical ;
|
- 3328. Override reason
- (UMLS (HL7) C1547894) =Idea or Concept =HL7 Vocabulary Version 2.5;
=No suggested values | - 3378. OXEPINAC
- (UMLS (NCI) C0069754) =Organic Chemical; Pharmacologic Substance
|
- 3329. Override required
- (UMLS (HL7) C1548368) =Idea or Concept =Override;
| - 3379. oxetane
- [cyclic ester, trimethylene oxide. ( CSP )] (UMLS (CSP) C0069755) =Organic Chemical ;
=epoxide;
|
- 3330. Override type
- (UMLS (HL7) C1547893) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Equivalence Override;
Extension Override;
Interval Override | - 3380. OXi-104
- [An anticancer drug being evaluated in combination with cisplatin. ( NCI )] (UMLS (NCI) C0796491) =Organic Chemical; Pharmacologic Substance
|
- 3331. overriding, non-propagating
- [The association is added to the existing context associated with the Act, but overrides an association with the same typeCode. However, this overriding association will not propagate to any descendant Acts reached by conducting ActRelationships (see contextControlCode). Examples: If an 'Author' Participation were marked as "Overriding, Non-Propagating" it means that the author will replace the set of author participations that have propagated from ancestor Acts. Furthermore, no author participations whatsoever will propagate to any child Acts that allow context to be propagated. ( HL7V3.0 )] (UMLS (HL7) C1552006) =Idea or Concept =ContextControlNonPropagating;
ContextControlOverriding | - 3381. OXIBENDAZOLE
- (UMLS (NCI) C0069763) =Organic Chemical; Pharmacologic Substance ;
|
- 3332. overriding, propagating
- [The association is added to the existing context associated with the Act, but overrides an association with the same typeCode. This overriding association will propagate to any descendant Acts reached by conducting ActRelationships (see contextControlCode). Examples: If an 'Author' Participation were marked as "Overriding, Propagating" it means that the author will replace the set of author participations that have propagated from ancestor Acts, and will itself be the only author to propagate to any child Acts that allow context to be propagated. ( HL7V3.0 )] (UMLS (HL7) C1552004) =Idea or Concept =ContextControlPropagating;
ContextControlOverriding | - 3382. OXICONAZOLE
- (UMLS (NCI) C0069765) =Organic Chemical; Pharmacologic Substance ;
=imidazole;
[DE102] ANTIFUNGAL, TOPICAL =OXICONAZOLE 1 % |
- 3333. Overweight (BMI
- [A status with BODY WEIGHT that is above certain standard of acceptable or desirable weight. In the scale of BODY MASS INDEX, overweight is defined as having a BMI of 25.0-29.9 kg/m2. Overweight may or may not be due to increases in body fat (ADIPOSE TISSUE), hence overweight does not equal "over fat".(MSH)] (UMLS (ICPC) C0497406) (Overweight (BMI ) =Sign or Symptom =ENDOCRINE, METABOLIC AND NUTRITIONAL; Diagnosis/Diseases Component
| - 3383. oxidation
- [Process in which molecules are split to give products that have unpaired electrons. ( NCI )] (UMLS (NCI) C0030011) =Molecular Function ;
=oxidation reduction reaction;
=peroxidation;
oxidative stress;
autooxidation;
|
- 3334. Overweight and obesity
- [ ] (UMLS (ICD9CM) C1561826) =Disease or Syndrome
| - 3384. oxidation reduction reaction
- [chemical reaction in which electrons are transferred from one reactant to another. ( CSP )] (UMLS (CSP) C0030012) =Molecular Function ;
=chemical reaction;
=electron transfer;
oxidation;
reduction;
|
- 3335. Overweight, obesity and other hyperalimentation
- [ ] (UMLS (ICD9CM) C1561827) =Disease or Syndrome
| - 3385. oxidative stress
- [damage to biological tissues caused by superoxide and other free radicals generated as a result of intoxication, antimicrobial cellular immunity, metabolic abnormality, or "normal" aging; do not confuse with HYPOXIA or HYPEROXIA. ( CSP )] (UMLS (NCI) C0242606) =Cell or Molecular Dysfunction ;
=oxidation;
injury |
- 3336. ovid
- [ ] (UMLS (CSP) C0599416) =Mammal ;
| - 3386. oxide
- [any compound of oxygen with an element or radical. ( CSP )] (UMLS (CSP) C0030015) =Inorganic Chemical ;
=anion;
Oxygen Compounds;
oxygen compound;
=nitrogen oxide;
sulfur oxide;
WATER;
hydroxide;
metal oxide;
aluminum oxide;
carbon dioxide;
carbon monoxide;
Hypochlorous Acid;
MAGNESIA;
nitrogen oxide;
peroxide;
SILICA;
WATER;
C.I. Pigment White 4;
Arsenic (III) Oxide;
LEAD MONOXIDE;
Calcium oxide;
manganese dioxide;
mercuric oxide;
ferumoxides;
Ferumoxsil |
- 3337. Ovidrel
- (UMLS (NCI) C0939421) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 3387. oxidized lipid
- [ ] (UMLS (CSP) C0597152) =Lipid ;
=lipid;
=lipid peroxide;
|
- 3338. Ovine
- [any of various ruminant mammals (genus Ovis) related to the goats but stockier and lacking a beard in the male; specifically, one (O. aries) long domesticated especially for its flesh and wool. ( CSP )] (UMLS (NCI) C1123019) Ovis aries;
sheep;
=Mammal =Ungulate;
| - 3388. Oxidoreductase Gene
- [Oxidoreductase Genes encode the class of enzymes that catalyze oxidation/reduction reactions (Oxidoreductases). The oxidized substrate is regarded as a hydrogen donor. Systematic enzyme names employ dehydrogenase wherever possible, or reductase; oxidase is only used where O2 is the acceptor. ( NCI )] (UMLS (NCI) C1335186) =Gene or Genome
|
- 3339. Ovine Sialomucin
- [A naturally occurring mucin glycoprotein. Ovine submaxillary mucin (OSM), extracted from an ovine submaxillary gland, provides a rich source of the sialylated Tn antigen (sTn) which is a carbohydrate antigen found on mucins of many epithelial tumors. Vaccination with OSM may result in the production of antibodies as well as elicit a cytotoxic T- lymphocyte (CTL) response against tumor cells expressing sTn, thereby resulting in decreased tumor cell growth. ( NCI )] (UMLS (NCI) C0279238) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 3389. oxidoreductase inhibitor
- [any substance or agent which suppresses, prevents or opposes the activity of enzymes which catalyze oxidation-reduction reactions. ( CSP )] (UMLS (CSP) C0597153) =Pharmacologic Substance ;
=enzyme inhibitor;
=MAO inhibitor;
6-Methoxy-alpha-methyl-2-naphthaleneacetic Acid;
cyclooxygenase inhibitor;
Xanthine Oxidase Inhibitor;
dopamine hydroxylase inhibitor;
|
- 3340. Ovis
- [Any of the ruminant mammals with curved horns in the genus Ovis, family Bovidae. They possess lachrymal grooves and interdigital glands, which are absent in GOATS. ( MSH )] (UMLS (CSP) C0036945) =Mammal
| - 3390. oxime
- [compounds containing the group C=NOH. ( CSP )] (UMLS (CSP) C0030020) =Organic Chemical ;
=Hydroxylamines;
nitrogen oxide =Fluoxamine;
Pralidoxime Compounds;
technetium Tc 99m teboroxime;
Fluoxamine |
- 3341. OVLT (organum vasculosum of the lamina terminalis)
- [ ] (UMLS (CSP) C0599521) =Body Part, Organ, or Organ Component ;
| - 3391. OXINDANAC
- (UMLS (NCI) C0069768) =Organic Chemical; Pharmacologic Substance ;
|
- 3342. Ovocylin
- (UMLS (NCI) C0699359) =Steroid; Pharmacologic Substance; Hormone ;
| - 3392. oxindole
- [ ] (UMLS (CSP) C0598684) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 3343. ovomucin
- [glycoprotein derived from egg white. ( CSP )] (UMLS (CSP) C0029960) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=egg protein;
| - 3393. OXINIACIC ACID
- (UMLS (NCI) C0873176) =Organic Chemical; Pharmacologic Substance
|
- 3344. Ovral
- (UMLS (NCI) C0728964) =Steroid; Pharmacologic Substance; Hormone
| - 3394. OXIPEROMIDE
- (UMLS (NCI) C0069771) =Organic Chemical; Pharmacologic Substance ;
|
- 3345. Ovrette
- (UMLS (NCI) C0699169) =Steroid; Pharmacologic Substance; Hormone
| - 3395. Oxiracetam
- (UMLS (NCI) C0069772) =Organic Chemical; Pharmacologic Substance ;
|
- 3346. ovulation
- [discharge of an ovum from a vesicular follicle of the ovary. ( CSP )] (UMLS (NCI) C0029965) =Organ or Tissue Function =oogenesis;
=ovulation detection/prediction;
| - 3396. OXO
- [The potassium salt of oxonate, an enzyme inhibitor that modulates 5- fluorouracil (5-FU) toxicity. Oxonate (Oxo), one of the components of the antineoplastic agent S1, inhibits the enzyme orotate phosphoribosyltransferase which catalyzes the conversion of 5-FU to its active or phosphorylated form, FUMP. Upon oral administration, Oxo is selectively distributed to the intracellular sites of tissues lining the small intestines, thereby, producing localized inhibitory effects within the gastrointestinal tract. As a result, 5-FU associated gastrointestinal toxic effects are reduced and the incidence of diarrhea or mucositis is decreased with S1 therapy. ( NCI )] (UMLS (NCI) C0393003) =Organic Chemical; Pharmacologic Substance ;
|
- 3347. OVULATION BLEEDING
- (UMLS (ICD9CM) C0156405) =Sign or Symptom
| - 3397. oxoacid lyase
- [ ] (UMLS (CSP) C0597154) =Amino Acid, Peptide, or Protein; Enzyme =carbon carbon lyase;
=citrate (si) synthase;
|
- 3348. ovulation detection
- [Method to determine the occurrence of OVULATION by direct or indirect means. Indirect methods examine the effects of PROGESTERONE on cervical mucus (CERVIX MUCUS), or basal body temperature. Direct ovulation detection, generally used in fertility treatment, involves analyses of circulating hormones in blood and ULTRASONOGRAPHY. ( MSH )] (UMLS (CSP) C0029966) =Diagnostic Procedure
| - 3398. oxoglutarate decarboxylase
- [ ] (UMLS (CSP) C0311624) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 3349. ovulation detection/prediction
- [method to determine or predict the occurrence of ovulation by direct or indirect means. ( CSP )] (UMLS (CSP) C0872073) =Organ or Tissue Function ;
=ovulation;
=ovulation time | - 3399. Oxolamine
- (UMLS (NCI) C0069787) =Organic Chemical; Pharmacologic Substance ;
|
- 3350. ovulation prediction
- [Predicting the time of OVULATION can be achieved by measuring the preovulatory elevation of ESTRADIOL; LUTEINIZING HORMONE or other hormones in BLOOD or URINE. Accuracy of ovulation prediction depends on the completeness of the hormone profiles, and the ability to determine the preovulatory LH peak. ( MSH )] (UMLS (CSP) C0920722) =Diagnostic Procedure ;
| - 3400. oxotremorine
- [A non-hydrolyzed muscarinic agonist used as a research tool. ( MSH )] (UMLS (CSP) C0030038) =Organic Chemical; Pharmacologic Substance
|
home
